Pharmstandard (Pharmaceuticals) Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 1,068

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 5

  • Investments
  • 31

Pharmstandard (Pharmaceuticals) General Information

Description

Manufacturer of pharmaceutical products based in Dolgoprudny, Russia. The company's products help in the treatment of cardiovascular diseases, diabetes mellitus, growth hormone deficiency, gastroenterological and infectious diseases, neurological and metabolic disorders, oncology and a variety of other diseases.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 5B, Likhachyovsky Proezd
  • Dolgoprudny, 141701
  • Russia
+7 8
Primary Industry
Pharmaceuticals
Parent Company
Vertical(s)
Corporate Office
  • 5B, Likhachyovsky Proezd
  • Dolgoprudny, 141701
  • Russia
+7 8

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharmstandard (Pharmaceuticals) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pharmstandard (Pharmaceuticals)‘s full profile, request access.

Request a free trial

Pharmstandard (Pharmaceuticals) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of pharmaceutical products based in Dolgoprudny, Russia. The company's products help in the treatment of ca
Pharmaceuticals
Dolgoprudny, Russia
1,068 As of 2016

Barcelona, Spain
 

Oeiras, Portugal
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pharmstandard (Pharmaceuticals) Competitors (9)

One of Pharmstandard (Pharmaceuticals)’s 9 competitors is Angelini Pharma España, a Corporation company based in Barcelona, Spain.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Angelini Pharma España Corporation Barcelona, Spain
Angelini Pharma Portugal Corporation Oeiras, Portugal
J. B. Chemicals & Pharmaceuticals Private Equity-Backed Mumbai, India
Casper Pharma Corporate Backed or Acquired East Brunswick, NJ
Angelini Pharma Türkiye Corporation Istanbul, Turkey
You’re viewing 5 of 9 competitors. Get the full list »

Pharmstandard (Pharmaceuticals) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pharmstandard (Pharmaceuticals) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pharmstandard (Pharmaceuticals)‘s full profile, request access.

Request a free trial

Pharmstandard (Pharmaceuticals) Investments & Acquisitions (31)

Pharmstandard (Pharmaceuticals)’s most recent deal was a Merger/Acquisition with Nanolek. The deal was made on 02-Sep-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Nanolek 02-Sep-2022 Merger/Acquisition Biotechnology
PET-Technology 18-Jul-2018 Merger/Acquisition Clinics/Outpatient Services
OncoTartis 11-Dec-2017 Later Stage VC Drug Discovery
TearSolutions 06-Dec-2017 Early Stage VC Drug Discovery
Viriom 06-Dec-2017 Later Stage VC Drug Discovery
You’re viewing 5 of 31 investments and acquisitions. Get the full list »

Pharmstandard (Pharmaceuticals) Exits (13)

Pharmstandard (Pharmaceuticals)’s most recent exit was on 05-Dec-2017 from Neon Therapeutics. The exit was categorized as with 11 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Neon Therapeutics 05-Dec-2017 Completed
  • 11 buyers
enGene (Biotechnology) 01-Mar-2017 Completed
Protagonist Therapeutics 11-Aug-2016 Completed
  • 6 buyers
Argos Therapeutics 28-Jul-2016 Completed
  • 3 buyers
Allena Pharmaceuticals 09-Dec-2015 Later Stage VC Completed
  • 8 buyers
You’re viewing 5 of 13 exits. Get the full list »

Pharmstandard (Pharmaceuticals) Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Nanolek Moscow, Russia 2011
PET-Technology Balashikha, Russia 2011

Pharmstandard (Pharmaceuticals) FAQs

  • When was Pharmstandard (Pharmaceuticals) founded?

    Pharmstandard (Pharmaceuticals) was founded in 2003.

  • Where is Pharmstandard (Pharmaceuticals) headquartered?

    Pharmstandard (Pharmaceuticals) is headquartered in Dolgoprudny, Russia.

  • What is the size of Pharmstandard (Pharmaceuticals)?

    Pharmstandard (Pharmaceuticals) has 1,068 total employees.

  • What industry is Pharmstandard (Pharmaceuticals) in?

    Pharmstandard (Pharmaceuticals)’s primary industry is Pharmaceuticals.

  • Is Pharmstandard (Pharmaceuticals) a private or public company?

    Pharmstandard (Pharmaceuticals) is a Private company.

  • What is Pharmstandard (Pharmaceuticals)’s current revenue?

    The current revenue for Pharmstandard (Pharmaceuticals) is .

  • How much funding has Pharmstandard (Pharmaceuticals) raised over time?

    Pharmstandard (Pharmaceuticals) has raised $880M.

  • Who are Pharmstandard (Pharmaceuticals)’s investors?

    Bristley Enterprises and Pharmstandard Leksredstva have invested in Pharmstandard (Pharmaceuticals).

  • Who are Pharmstandard (Pharmaceuticals)’s competitors?

    Angelini Pharma España, Angelini Pharma Portugal, J. B. Chemicals & Pharmaceuticals, Casper Pharma, and Angelini Pharma Türkiye are some of the 9 competitors of Pharmstandard (Pharmaceuticals).

  • When was Pharmstandard (Pharmaceuticals) acquired?

    Pharmstandard (Pharmaceuticals) was acquired on 14-Sep-2016.

  • Who acquired Pharmstandard (Pharmaceuticals)?

    Pharmstandard (Pharmaceuticals) was acquired by Augment Investments.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »